The longer trials take the higher the chance of competition gaining their own traction. Other cbd biotech's can AVE their own skin delivery system too, there's not just permetrex.
With lockdown's, the canine move was probably a needed strategic one. Whether they are right or wrong, it's where we are atm.
where to for SP? Chart looks bearish. Need positive news, when it comes.
Thankyou.
The longer trials take the higher the chance of competition...
-
- There are more pages in this discussion • 8,886 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |